These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neuroprotective Effect of Plasminogen Activator Inhibitor-1 Antagonist in the Rat Model of Mild Traumatic Brain Injury. Kuru Bektaşoğlu P; Koyuncuoğlu T; Akbulut S; Akakın D; Eyüboğlu İP; Erzik C; Yüksel M; Kurtel H Inflammation; 2021 Dec; 44(6):2499-2517. PubMed ID: 34460025 [TBL] [Abstract][Full Text] [Related]
8. Effects of aging and hypertension on cerebral ischemic susceptibility: evidenced by MR diffusion-perfusion study in rat. Lee TH; Liu HL; Yang ST; Yang JT; Yeh MY; Lin JR Exp Neurol; 2011 Feb; 227(2):314-21. PubMed ID: 21146526 [TBL] [Abstract][Full Text] [Related]
9. Impact of stroke co-morbidities on cortical collateral flow following ischaemic stroke. Biose IJ; Dewar D; Macrae IM; McCabe C J Cereb Blood Flow Metab; 2020 May; 40(5):978-990. PubMed ID: 31234703 [TBL] [Abstract][Full Text] [Related]
10. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Nishimura Y; Ito T; Saavedra JM Stroke; 2000 Oct; 31(10):2478-86. PubMed ID: 11022082 [TBL] [Abstract][Full Text] [Related]
12. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. Zhang ZG; Chopp M; Goussev A; Lu D; Morris D; Tsang W; Powers C; Ho KL J Neurosci; 1999 Dec; 19(24):10898-907. PubMed ID: 10594071 [TBL] [Abstract][Full Text] [Related]
14. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats. Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice. Denorme F; Wyseure T; Peeters M; Vandeputte N; Gils A; Deckmyn H; Vanhoorelbeke K; Declerck PJ; De Meyer SF Stroke; 2016 Sep; 47(9):2419-22. PubMed ID: 27470988 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Flow-Mediated Dilation of Pial Collaterals and the Effect of Hypertension. Li Z; Cipolla MJ Hypertension; 2022 Feb; 79(2):457-467. PubMed ID: 34856815 [TBL] [Abstract][Full Text] [Related]
17. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke. Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413 [TBL] [Abstract][Full Text] [Related]
18. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Tejima E; Katayama Y; Suzuki Y; Kano T; Lo EH Stroke; 2001 Jun; 32(6):1336-40. PubMed ID: 11387496 [TBL] [Abstract][Full Text] [Related]
19. Oxotremorine-induced cerebral hyperemia does not predict infarction volume in spontaneously hypertensive or stroke-prone rats. Harukuni I; Takahashi H; Traystman RJ; Bhardwaj A; Kirsch JR Crit Care Med; 2000 Jan; 28(1):190-5. PubMed ID: 10667521 [TBL] [Abstract][Full Text] [Related]
20. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats. Izuta M; Clavier N; Kirsch JR; Traystman RJ Stroke; 1995 Jun; 26(6):1079-85. PubMed ID: 7539167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]